Open AccessAbstract 3179: TORC1/2 inhibition sensitizes MYC-driven medulloblastoma cells to carboplatin chemotherapy
Author(s) -
Rachael Maynard
Publication year - 2018
Publication title -
cancer research
Language(s) - Uncategorized
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2018-3179
Subject(s) - medulloblastoma , medicine , cancer research , apoptosis , carboplatin , neural stem cell , pi3k/akt/mtor pathway , chemotherapy , stem cell , oncology , biology , cisplatin , genetics , biochemistry